Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-25 @ 8:24 PM
Study NCT ID:
NCT03589469
Status:
COMPLETED
Last Update Posted:
2023-08-29
First Post:
2018-05-04
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor:
ADC Therapeutics S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-09
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-04
First Submit QC Date:
None
Study First Post Date:
2018-07-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-05-20
Results First Submit QC Date:
None
Results First Post Date:
2021-07-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-03
Last Update Post Date:
2023-08-29
Last Update Post Date Type:
ACTUAL